Zhuojun Ling

Statistics

Publications

Citations

1.2K

H-Index

Active since

2019

Affiliations

Institute of Hematology & Blood Diseases Hospital(Current)

Beijing Tongren Hospital

Chinese Academy of Medical Sciences & Peking Union Medical College

Shanghai Pulmonary Hospital

Tongji University

Zhuojun Ling is an author at Institute of Hematology & Blood Diseases Hospital specializing in immunotherapy, cytotoxic t lymphocyte responses, and chimeric antigen receptor t-cell therapy.

Publications per year

2019–2024

Publications

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

Jing Pan, Yue Tan, Guoling Wang et al. · Journal of Clinical Oncology · 2021 · 294 citations

Life Sciences, Hematology, Immunology +15

CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia

Jing Pan, Qing Niu, Biping Deng et al. · Leukemia · 2019 · 251 citations · Full text

Medicine, Hematology, Oncology +17

Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia

Shuangyou Liu, Biping Deng, Zhichao Yin et al. · Blood Cancer Journal · 2020 · 159 citations · Full text

Life Sciences, Immunology, Oncology +12

Ruxolitinib mitigates steroid‐refractory CRS during CAR T therapy

Jing Pan, Biping Deng, Zhuojun Ling et al. · Journal of Cellular and Molecular Medicine · 2020 · 91 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia

Yue Tan, Lingling Shan, Liping Zhao et al. · Journal of Hematology & Oncology · 2023 · 84 citations · Full text

Life Sciences, Hematology, Immunology +17

1–5 of 16